These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 18173815)

  • 21. Opioid rotation from high-dose morphine to transdermal buprenorphine (Transtec) in chronic pain patients.
    Freye E; Anderson-Hillemacher A; Ritzdorf I; Levy JV
    Pain Pract; 2007 Jun; 7(2):123-9. PubMed ID: 17559481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Challenging the equipotency calculation for transdermal buprenorphine: four case studies.
    Likar R; Krainer B; Sittl R
    Int J Clin Pract; 2008 Jan; 62(1):152-6. PubMed ID: 18173815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of transdermal buprenorphine in the treatment of cancer pain: an expert panel consensus.
    Pergolizzi JV; Mercadante S; Echaburu AV; Van den Eynden B; Fragoso RM; Mordarski S; Lybaert W; Beniak J; Orońska A; Slama O;
    Curr Med Res Opin; 2009 Jun; 25(6):1517-28. PubMed ID: 19435402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transdermal buprenorphine in cancer pain and palliative care.
    Sittl R
    Palliat Med; 2006; 20 Suppl 1():s25-30. PubMed ID: 16764218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transdermal buprenorphine in the treatment of chronic pain.
    Sittl R
    Expert Rev Neurother; 2005 May; 5(3):315-23. PubMed ID: 15938664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical update on the pharmacology, efficacy and safety of transdermal buprenorphine.
    Kress HG
    Eur J Pain; 2009 Mar; 13(3):219-30. PubMed ID: 18567516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Buprenorphine and the transdermal system: the ideal match in pain management.
    Budd K
    Int J Clin Pract Suppl; 2003 Feb; (133):9-14; discussion 23-4. PubMed ID: 12665118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Transdermal buprenorphine: a current overview of pharmacological and clinical data].
    Faymonville ME; Libbrecht D
    Rev Med Liege; 2008 Nov; 63(11):671-6. PubMed ID: 19112993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Buprenorphine: new tricks with an old molecule for pain management.
    Heit HA; Gourlay DL
    Clin J Pain; 2008 Feb; 24(2):93-7. PubMed ID: 18209513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Opioid switching and rotation in primary care: implementation and clinical utility.
    Slatkin NE
    Curr Med Res Opin; 2009 Sep; 25(9):2133-50. PubMed ID: 19601703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of chronic pain in the elderly: focus on transdermal buprenorphine.
    Vadivelu N; Hines RL
    Clin Interv Aging; 2008; 3(3):421-30. PubMed ID: 18982913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Driving ability under opioids: current assessment of published studies].
    Sabatowski R
    Dtsch Med Wochenschr; 2008 Jun; 133 Suppl 2():S25-8. PubMed ID: 18548365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The marginalization of chronic pain patients on chronic opioid therapy.
    Peppin JF
    Pain Physician; 2009; 12(3):493-8. PubMed ID: 19461818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Low-dose strong opioid (LDSO)--treatment of pain in osteoarthritis].
    Bolten WW; Böhme K; Grifka J; Schutter U; Schwarz H; Sittl R; Sturm D; Wahle K
    MMW Fortschr Med; 2008 Dec; 150(51-52):41. PubMed ID: 19156956
    [No Abstract]   [Full Text] [Related]  

  • 36. Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines.
    Trescot AM; Helm S; Hansen H; Benyamin R; Glaser SE; Adlaka R; Patel S; Manchikanti L
    Pain Physician; 2008 Mar; 11(2 Suppl):S5-S62. PubMed ID: 18443640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of opioids in the treatment of chronic non-cancer pain.
    Trescot AM; Glaser SE; Hansen H; Benyamin R; Patel S; Manchikanti L
    Pain Physician; 2008 Mar; 11(2 Suppl):S181-200. PubMed ID: 18443639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opioid induced hyperalgesia: clinical implications for the pain practitioner.
    Silverman SM
    Pain Physician; 2009; 12(3):679-84. PubMed ID: 19461836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of opioids for chronic pain: a review of the evidence.
    Ballantyne JC; Shin NS
    Clin J Pain; 2008; 24(6):469-78. PubMed ID: 18574357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delivery systems of opioid analgesics for pain relief: a review.
    Leppert W; Krajnik M; Wordliczek J
    Curr Pharm Des; 2013; 19(41):7271-93. PubMed ID: 23489205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.